Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stages.
Paulmann M, Heuer R, Annecke T, Behr B, Boch K, Boos AM, Brockow K, French LE, Gille J, Gundlach V, Hartmann B, Höger P, Hofmann SC, Klein T, Lehnhardt M, Liß Y, Maier P, Mandel P, Marathovouniotis N, Marlok F, Mittelviefhaus H, Pleyer U, Pradeau M, Rall K, Rieg S, Rittner H, Sander F, Schnitzler S, Schut C, Stolle A, Vorobyev A, Wedi B, Weiss J, Zepp M, Ziemer M, Mockenhaupt M, Nast A. Paulmann M, et al. Among authors: pradeau m. J Dtsch Dermatol Ges. 2024 Nov;22(11):1576-1593. doi: 10.1111/ddg.15516. Epub 2024 Oct 17. J Dtsch Dermatol Ges. 2024. PMID: 39417754
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapy.
Heuer R, Paulmann M, Annecke T, Behr B, Boch K, Boos AM, Brockow K, French LE, Gille J, Gundlach V, Hartmann B, Höger P, Hofmann SC, Klein T, Lehnhardt M, Liß Y, Maier P, Mandel P, Marathovouniotis N, Marlok F, Mittelviefhaus H, Pleyer U, Pradeau M, Rall K, Rieg S, Rittner H, Sander F, Schnitzler S, Schut C, Stolle A, Vorobyev A, Wedi B, Weiss J, Zepp M, Ziemer M, Mockenhaupt M, Nast A. Heuer R, et al. Among authors: pradeau m. J Dtsch Dermatol Ges. 2024 Oct;22(10):1448-1466. doi: 10.1111/ddg.15515. Epub 2024 Sep 23. J Dtsch Dermatol Ges. 2024. PMID: 39314017
Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
Gignac T, Trépanier G, Pradeau M, Morissette A, Agrinier AL, Larose É, Marois J, Pilon G, Gagnon C, Vohl MC, Marette A, Carreau AM. Gignac T, et al. Among authors: pradeau m. Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E616-E625. doi: 10.1152/ajpendo.00294.2023. Epub 2024 Mar 13. Am J Physiol Endocrinol Metab. 2024. PMID: 38477665
Tissue pleiotropic effect of biotin and prebiotic supplementation in established obesity.
Voland L, Yuan M, Lecoutre S, Debédat J, Pelloux V, Pradeau M, Coles E, Merabtene F, Zhang C, Mardinoglu A, Le Roy T, Soula H, Clément K. Voland L, et al. Among authors: pradeau m. Am J Physiol Endocrinol Metab. 2023 Aug 30. doi: 10.1152/ajpendo.00295.2022. Online ahead of print. Am J Physiol Endocrinol Metab. 2023. PMID: 37646578
Deep phenotyping and biomarkers of various dairy fat intakes in an 8-week randomized clinical trial and 2-year swine study.
Martin JC, Bal-Dit-Sollier C, Bard JM, Lairon D, Bonneau M, Kang C, Cazaubiel M, Marmonier C, Leruyet P, Boyer C, Nazih H, Tardivel C, Defoort C, Pradeau M, Bousahba I, Hammou H, Svilar L, Drouet L. Martin JC, et al. Among authors: pradeau m. J Nutr Biochem. 2023 Mar;113:109239. doi: 10.1016/j.jnutbio.2022.109239. Epub 2022 Nov 26. J Nutr Biochem. 2023. PMID: 36442717 Free article. Clinical Trial.